Agilent Technologies, Inc. $A Shares Purchased by Bank of Nova Scotia

Bank of Nova Scotia increased its stake in Agilent Technologies, Inc. (NYSE:A) by 71.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 129,240 shares of the medical research company’s stock after purchasing an additional 53,965 shares during the quarter. Bank of Nova Scotia’s holdings in Agilent Technologies were worth $14,731,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA grew its stake in shares of Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after purchasing an additional 1,713,216 shares during the last quarter. State Street Corp grew its position in Agilent Technologies by 1.9% during the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after purchasing an additional 241,029 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after acquiring an additional 25,139 shares in the last quarter. Morgan Stanley raised its stake in shares of Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after purchasing an additional 692,202 shares in the last quarter. Finally, Norges Bank acquired a new stake in Agilent Technologies in the fourth quarter valued at approximately $549,158,000.

Agilent Technologies Price Performance

NYSE A opened at $138.65 on Friday. The stock has a market cap of $39.16 billion, a price-to-earnings ratio of 27.84, a PEG ratio of 2.46 and a beta of 1.25. The business has a 50 day simple moving average of $129.75 and a 200 day simple moving average of $125.55. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.27. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same period last year, the company earned $1.31 earnings per share. Agilent Technologies’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts anticipate that Agilent Technologies, Inc. will post 6.01 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th were issued a dividend of $0.255 per share. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on A. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Sanford C. Bernstein assumed coverage on Agilent Technologies in a research report on Friday, June 26th. They set an “outperform” rating and a $155.00 price objective on the stock. Piper Sandler initiated coverage on Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective on the stock. TD Cowen increased their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, Royal Bank Of Canada began coverage on shares of Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price target on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $159.35.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.